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A 53-year-old gentleman presented with a painless lump in hypogastrium for 6 months. He also complained of increased frequency of urination, dysuria and constipation. 
The patient reported to have cough with expectoration containing 
occasional blood stained sputum. On examination, a 6 × 5 cm 
well defined, smooth, non-tender, and hard lump with impalpable 
lower margin was found occupying the hypogastrium (Fig. 1). 
Per-rectal examination revealed a mass arising from the left pelvic 
wall and compromising the rectal lumen but with retained mucosal 
integrity.
Ultrasonography of abdomen revealed 9 × 8 cm homogenous, 
hypoechoic, solid mass with significant vascularity arising 
from the left lateral pelvic wall with left side moderate hydro-
ureteronephrosis. Contrast enhanced computer tomography 
(CECT) of the abdomen demonstrated a homogenous, well 
demarcated, hypo attenuated mass of 12.6 × 10.6 cm originating 
from the left lateral pelvic wall with significant contrast 
enhancement (Fig. 2). The tumor was compressing on the rectum 
and bladder, with maintained fat planes. Radiograph of chest 
showed multiple canon ball lesions (Fig. 3). CT of head and bone 
scan was normal.
Tumor resection was not contemplated due to the presence 
of pulmonary lesions. Multiple chunks retrieved through tru cut 
biopsy of the lump were found to be unsuitable by the pathologist 
to formulate a definitive diagnosis. Incision biopsy of tumor was 
carried out as the next step to aid in tissue diagnosis. Histology 
suggested spindle cell tumor with mild nuclear atypical, but no 
mitotic figures. Immunohistochemistry (IHC) was positive for 
CD-34, CD-99, and bcl-2, Vimentin and KI 67<1%; however, 
markers for Actin, Desman and S-100 were negative (Fig. 4). 
High resolution CT thorax revealed multiple pulmonary nodules, 
and CT guided biopsy confirmed spindle cell nature of the 
pulmonary nodule.
QUESTIONS
1: What is the diagnosis?
2: What should be the plan of management in this patient?
Figure 1: The patient presented with hypogastria lump and 
compressive symptoms on bladder and rectum
Figure 2: (a) Contrast enhanced computer tomography pelvis: Axial 
view showing well defined encapsulated heterogeneous pelvic mass 
12.6 ×10.6 cm from the left lateral pelvic wall, (b) the mass has few 
necrotic areas within it and significant uniform post intravenous 
contrast enhancement. The mass was displacing rectal/bladder wall 
with maintained fat planes, (c) pelvic mass leads to obstruction of 
the left kidney drainage (moderate left side hydroureteronephrosis)
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ANSWER 1
Histopathology was suggestive of solitary fibrous tumor (SFT). 
This rare soft tissue sarcoma of mesenchyme cell origin closely 
resembles hemangiopericytoma (an extremely vascular tumor). 
In 2006, WHO identifies SFT as a distinctive entity from 
hemangiopericytoma. SFT can arise in mesothelium tissues 
(pleura, peritoneum, and pericardium), soft tissues and visceral 
organs (lung, meninges, thigh, thyroid, breast, nose, pharynx 
etc.,) [1]. The most common site of SFT is pleura. Calcification 
(26%), hypoglycemia, osteodystrophy, arthralgia, and clubbing 
are the common manifestations in pleural SFT. It usually has 
a benign clinical course, but prone to recur either locally or at 
distant sites despite clear margin of resection. In the absence 
of specific imaging characteristics that can aid in the diagnosis 
histopathological examination complemented by IHC study is 
considered the cornerstone for identification of SFT. Expression 
of CD-34 positive markers with negative S-100 markers is highly 
suggestive of a diagnosis of SFT. The malignant lesions are 
characterized by large tumor size, sessile growths, high mitotic 
index (>4 mitotic figures/10 HPF), nuclear pleomorphic, high 
cellularity and the presence of necrosis and/or hemorrhage. The 
relationship between histological features and clinical behavior of 
SFT is not so clear and the tumor has an unpredictable course [2].
Answer 2
Complete surgical excision is the primary modality of treatment. 
The quality of initial excision in achieving tumor free margins 
is considered the most important prognostic factor. Adequate 
surgical resection has been associated with a 10 years survival rate 
of 54-89% in patients with localized SFT. Radiotherapy had been 
attempted in a number of patients for local tumor control when 
resection margins were found to be involved on histopathological 
examination. In patients having unresectable and metastatic SFT 
anticancer drugs (anthracyclines with or without ifosfamide or 
trabectedin, and gemcitabine with docetaxel), and anti-antigenic 
drugs (bevacizumab combined with temozolomide) are tried with 
a partial/no response. Few authors have achieved long term tumor 
control with sunitinib, sorafenib, or imagine [3]. The goal of 
treatment in our patient was to improve on the local compressive 
effects of the tumor as well as to prolong the progression free 
survival. Two sittings of tumor embolization combined with oral 
sorafenib (200 mg/day) managed to arrest the tumor progression 
(assessed by high-resolution computed tomography thorax and 
CECT scan of pelvis) over a period of 1 year (Fig. 5). Subsequently 
the patient opted out of the treatment due to financial constraints 
and succumbed to fulminant pneumonia and respiratory failure 
within 6 months of discontinuation of palliative therapy.
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Figure 4: Histopathology and immuno-histochemistry of pelvic mass
Figure 5: Contrast enhanced computer tomography pelvis axial 
view, one month post embolization tumor have increased area of 
necrosis, however no significant reduction in size of tumor
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Figure 3: (a) Chest radiograph showing multiple nodules of various 
sizes at basal and sub-pleural location, (b and c) lung and mediastina 
window of high-resolution computed tomography thorax (axial 
view) showing multiple sharply defined rounded pulmonary nodule 
of various size
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